Sarepta Therapeutics | Netto Inntekt

Net Income Endring Dato
Acadia Pharmaceuticals USD 16.56M 29.24M 2024-03
Agios Pharmaceuticals USD -81549000 14.39M 2024-03
Alnylam Pharmaceuticals USD -65935000 71.94M 2024-03
Amgen USD -113000000 880M 2024-03
Avrobio USD -6808000 1.98M 2024-03
Biogen USD 393.4M 143.7M 2024-03
BioMarin Pharmaceutical USD 88.66M 68.29M 2024-03
Daiichi Sankyo JPY 66.56B 26.56B 2023-12
Eli Lilly USD 2.24B 53.3M 2024-03
Gilead Sciences USD -4170000000 5.6B 2024-03
Incyte USD 169.55M 31.53M 2024-03
Insmed USD -157091000 28.97M 2024-03
Ionis Pharmaceuticals USD -142803000 133.54M 2024-03
Moderna USD -1175000000 1.39B 2024-03
Neurocrine Biosciences USD 43.4M 39.7M 2024-03
Pfizer USD 3.12B 6.48B 2024-03
PTC Therapeutics USD -91576000 64.22M 2024-03
Regeneron Pharmaceuticals USD 722M 437.6M 2024-03
Roche Holding CHF 7.14B 3.25B 2023-06
Sanofi EUR 1.13B 1.39B 2024-03
Sarepta Therapeutics USD 36.12M 77.06M 2024-03
Ultragenyx Pharmaceutical USD -170684000 47.49M 2024-03
Vertex Pharmaceuticals USD 1.1B 64.3M 2024-03



Sarepta Therapeutics Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.